Search research articles
Contact Us
Filters
Showing results (161-170 of 166) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 166 results.
Pharmacological Reviews
|
November 13, 2013
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors
Francoise Bachelerie, Adit Ben-Baruch, Amanda M Burkhardt, et al.
Brain Communications
|
August 19, 2021
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2
Ilaria Giovannelli, Nadhim Bayatti, Abigail Brown, et al.
Immunity
|
July 19, 2014
Macrophage activation and polarization: nomenclature and experimental guidelines
Peter J Murray, Judith E Allen, Subhra K Biswas, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 30, 2004
Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury
Riccardo Bertini, Marcello Allegretti, Cinzia Bizzarri, et al.
Immunity
|
January 27, 2026
Tumor-associated macrophages enhance peripheral nerve tumor infiltration and spinal cord repair
Sissi Dolci, Loris Mannino, Eros Rossi, et al.
Lancet (London, England)
|
May 12, 2025
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial
Gilbert Bensimon, P Nigel Leigh, Timothy Tree, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 166) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 166 results.
Pharmacological Reviews
|
November 13, 2013
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors
Francoise Bachelerie, Adit Ben-Baruch, Amanda M Burkhardt, et al.
Brain Communications
|
August 19, 2021
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2
Ilaria Giovannelli, Nadhim Bayatti, Abigail Brown, et al.
Immunity
|
July 19, 2014
Macrophage activation and polarization: nomenclature and experimental guidelines
Peter J Murray, Judith E Allen, Subhra K Biswas, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 30, 2004
Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury
Riccardo Bertini, Marcello Allegretti, Cinzia Bizzarri, et al.
Immunity
|
January 27, 2026
Tumor-associated macrophages enhance peripheral nerve tumor infiltration and spinal cord repair
Sissi Dolci, Loris Mannino, Eros Rossi, et al.
Lancet (London, England)
|
May 12, 2025
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial
Gilbert Bensimon, P Nigel Leigh, Timothy Tree, et al.
Page
of 17